What is the conclusion of the ALIAS Parts 1 and 2 and NETT Investigators study?
The conclusion of the ALIAS Parts 1 and 2 and NETT Investigators study was that high-dose albumin treatment for acute ischemic stroke may improve functional outcome and reduce mortality.